Dr. Belen A. Nunez Cespedes, MD

Dr. Nunez Cespedes practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Nunez Cespedes' NPI, 1780081059, was assigned on December 2, 2014. Dr. Nunez Cespedes holds Virginia license 0101266086.

Dr. Nunez Cespedes' primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Nunez Cespedes' primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Nunez Cespedes to 2 more dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nunez Cespedes practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Nunez Cespedes' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Nunez Cespedes is licensed in Virginia.

CMS data shows 698 Medicare services from Dr. Nunez Cespedes across 9 procedure codes in 2024, for 257 Medicare patients. Medicare paid $59,005 for them.

CMS counts 257 Medicare patients who saw Dr. Nunez Cespedes in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 3.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nunez Cespedes' median patient age at 64, with 53% women.

In 2024, Dr. Nunez Cespedes wrote 439 Medicare Part D claims for 102 patients. 81% of them were for generic drugs. CMS names the drug for 305 of them, across 10 drugs with 11 or more claims each, at $74,551 in total drug cost. In 2023, CMS named 45 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Nunez Cespedes for performance year 2024, reported through an alternative payment model (APM). Dr. Nunez Cespedes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nunez Cespedes as offering telehealth.

CMS Open Payments shows 18 general payments to Dr. Nunez Cespedes from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 60% of the total. Akebia Therapeutics Inc paid the most, $287.